Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Activity and Functional Importance of Helicobacter pylori Virulence Factors.

Sgouras D, Tegtmeyer N, Wessler S.

Adv Exp Med Biol. 2019 Apr 24. doi: 10.1007/5584_2019_358. [Epub ahead of print]

PMID:
31016624
2.

Hybrid therapy as first-line regimen for Helicobacter pylori eradication in a high clarithromycin resistance area: a prospective open-label trial.

Georgopoulos SD, Papastergiou V, Martinez-Gonzalez B, Xirouchakis E, Familias I, Sgouras D, Mentis A, Karatapanis S.

Ann Gastroenterol. 2018 Mar-Apr;31(2):205-210. doi: 10.20524/aog.2017.0221. Epub 2017 Dec 15.

3.

Helicobacter pylori Adapts to Chronic Infection and Gastric Disease via pH-Responsive BabA-Mediated Adherence.

Bugaytsova JA, Björnham O, Chernov YA, Gideonsson P, Henriksson S, Mendez M, Sjöström R, Mahdavi J, Shevtsova A, Ilver D, Moonens K, Quintana-Hayashi MP, Moskalenko R, Aisenbrey C, Bylund G, Schmidt A, Åberg A, Brännström K, Königer V, Vikström S, Rakhimova L, Hofer A, Ögren J, Liu H, Goldman MD, Whitmire JM, Ådén J, Younson J, Kelly CG, Gilman RH, Chowdhury A, Mukhopadhyay AK, Nair GB, Papadakos KS, Martinez-Gonzalez B, Sgouras DN, Engstrand L, Unemo M, Danielsson D, Suerbaum S, Oscarson S, Morozova-Roche LA, Olofsson A, Gröbner G, Holgersson J, Esberg A, Strömberg N, Landström M, Eldridge AM, Chromy BA, Hansen LM, Solnick JV, Lindén SK, Haas R, Dubois A, Merrell DS, Schedin S, Remaut H, Arnqvist A, Berg DE, Borén T.

Cell Host Microbe. 2017 Mar 8;21(3):376-389. doi: 10.1016/j.chom.2017.02.013.

4.

Randomized clinical trial comparing ten day concomitant and sequential therapies for Helicobacter pylori eradication in a high clarithromycin resistance area.

Georgopoulos SD, Xirouchakis E, Martinez-Gonzales B, Zampeli E, Grivas E, Spiliadi C, Sotiropoulou M, Petraki K, Zografos K, Laoudi F, Sgouras D, Mentis A, Kasapidis P, Michopoulos S.

Eur J Intern Med. 2016 Jul;32:84-90. doi: 10.1016/j.ejim.2016.04.011. Epub 2016 Apr 28.

PMID:
27134145
5.

Helicobacter pylori CagA protein induces factors involved in the epithelial to mesenchymal transition (EMT) in infected gastric epithelial cells in an EPIYA- phosphorylation-dependent manner.

Sougleri IS, Papadakos KS, Zadik MP, Mavri-Vavagianni M, Mentis AF, Sgouras DN.

FEBS J. 2016 Jan;283(2):206-20. doi: 10.1111/febs.13592. Epub 2015 Dec 11.

6.

Helicobacter pylori Activates Matrix Metalloproteinase 10 in Gastric Epithelial Cells via EGFR and ERK-mediated Pathways.

Costa AM, Ferreira RM, Pinto-Ribeiro I, Sougleri IS, Oliveira MJ, Carreto L, Santos MA, Sgouras DN, Carneiro F, Leite M, Figueiredo C.

J Infect Dis. 2016 Jun 1;213(11):1767-76. doi: 10.1093/infdis/jiw031. Epub 2016 Jan 21.

PMID:
26802142
7.

Pathogenesis of Helicobacter pylori Infection.

Sgouras DN, Trang TT, Yamaoka Y.

Helicobacter. 2015 Sep;20 Suppl 1:8-16. doi: 10.1111/hel.12251. Review.

8.

Genetic variability of human metapneumo- and bocaviruses in children with respiratory tract infections.

Pogka V, Moutousi A, Kossyvakis A, Kalliaropoulos A, Sgouras DN, Giannaki M, Mentis AF.

Influenza Other Respir Viruses. 2014 Jan;8(1):107-15. doi: 10.1111/irv.12185. Epub 2013 Nov 7.

9.

Clinical evaluation of a ten-day regimen with esomeprazole, metronidazole, amoxicillin, and clarithromycin for the eradication of Helicobacter pylori in a high clarithromycin resistance area.

Georgopoulos SD, Xirouchakis E, Martinez-Gonzalez B, Sgouras DN, Spiliadi C, Mentis AF, Laoudi F.

Helicobacter. 2013 Dec;18(6):459-67. doi: 10.1111/hel.12062. Epub 2013 May 29.

PMID:
23714140
10.

Presence of terminal EPIYA phosphorylation motifs in Helicobacter pylori CagA contributes to IL-8 secretion, irrespective of the number of repeats.

Papadakos KS, Sougleri IS, Mentis AF, Hatziloukas E, Sgouras DN.

PLoS One. 2013;8(2):e56291. doi: 10.1371/journal.pone.0056291. Epub 2013 Feb 7.

11.

A mutagenesis method for the addition and deletion of highly repetitive DNA regions: the paradigm of EPIYA motifs in the cagA gene of Helicobacter pylori.

Papadakos KS, Sougleri IS, Mentis AF, Sgouras DN.

Helicobacter. 2013 Jun;18(3):229-41. doi: 10.1111/hel.12029. Epub 2012 Nov 27.

PMID:
23190444
12.

c-Src and c-Abl kinases control hierarchic phosphorylation and function of the CagA effector protein in Western and East Asian Helicobacter pylori strains.

Mueller D, Tegtmeyer N, Brandt S, Yamaoka Y, De Poire E, Sgouras D, Wessler S, Torres J, Smolka A, Backert S.

J Clin Invest. 2012 Apr;122(4):1553-66. doi: 10.1172/JCI61143. Epub 2012 Mar 1.

13.

Helicobacter pylori isolates from Greek children express type 2 and type 1 Lewis and α1,6-glucan antigens in conjunction with a functional type IV secretion system.

Altman E, Chandan V, Harrison BA, Panayotopoulou EG, Roma-Giannikou E, Li J, Sgouras DN.

J Med Microbiol. 2012 Apr;61(Pt 4):559-66. doi: 10.1099/jmm.0.038729-0. Epub 2011 Dec 8.

PMID:
22160312
14.

Expansion of European vacA and cagA alleles to East-Asian Helicobacter pylori strains in Cambodia.

Breurec S, Guillard B, Hem S, Papadakos KS, Brisse S, Huerre M, Monchy D, Oung C, Sgouras DN, Tan TS, Thiberge JM, Vong S, Raymond J, Linz B.

Infect Genet Evol. 2011 Dec;11(8):1899-905. doi: 10.1016/j.meegid.2011.08.007. Epub 2011 Aug 17.

PMID:
21871583
15.

Respiratory viruses involved in influenza-like illness in a Greek pediatric population during the winter period of the years 2005-2008.

Pogka V, Kossivakis A, Kalliaropoulos A, Moutousi A, Sgouras D, Panagiotopoulos T, Chrousos GP, Theodoridou M, Syriopoulou VP, Mentis AF.

J Med Virol. 2011 Oct;83(10):1841-8. doi: 10.1002/jmv.22173.

PMID:
21837803
16.

Clinical relevance of cagA and vacA gene polymorphisms in Helicobacter pylori isolates from Senegalese patients.

Breurec S, Michel R, Seck A, Brisse S, Côme D, Dieye FB, Garin B, Huerre M, Mbengue M, Fall C, Sgouras DN, Thiberge JM, Dia D, Raymond J.

Clin Microbiol Infect. 2012 Feb;18(2):153-9. doi: 10.1111/j.1469-0691.2011.03524.x. Epub 2011 Jul 1.

17.

Molecular and phylogenetic analysis of Greek measles 2010 strains.

Melidou A, Gioula G, Pogka V, Exindari M, Moutoussi A, Sgouras D, Papadakos K, Chatzidimitriou D, Karabaxoglou D, Mentis A, Malisiovas N.

Epidemiol Infect. 2012 Mar;140(3):432-8. doi: 10.1017/S095026881100094X. Epub 2011 May 31.

PMID:
21676352
18.

Endoscopic tests for the diagnosis of Helicobacter pylori infection in children: Validation of rapid urease test.

Roma-Giannikou E, Roubani A, Sgouras DN, Panayiotou J, van-Vliet C, Polyzos A, Roka K, Daikos G.

Helicobacter. 2010 Jun;15(3):227-32. doi: 10.1111/j.1523-5378.2010.00756.x.

PMID:
20557365
19.

CagA and VacA polymorphisms are associated with distinct pathological features in Helicobacter pylori-infected adults with peptic ulcer and non-peptic ulcer disease.

Panayotopoulou EG, Sgouras DN, Papadakos KS, Petraki K, Breurec S, Michopoulos S, Mantzaris G, Papatheodoridis G, Mentis A, Archimandritis A.

J Clin Microbiol. 2010 Jun;48(6):2237-9. doi: 10.1128/JCM.00662-10. Epub 2010 Apr 14.

20.

Laboratory investigation and phylogenetic analysis of enteroviruses involved in an aseptic meningitis outbreak in Greece during the summer of 2007.

Logotheti M, Pogka V, Horefti E, Papadakos K, Giannaki M, Pangalis A, Sgouras D, Mentis A.

J Clin Virol. 2009 Nov;46(3):270-4. doi: 10.1016/j.jcv.2009.07.019. Epub 2009 Aug 20.

PMID:
19699142
21.

CagA and VacA polymorphisms do not correlate with severity of histopathological lesions in Helicobacter pylori-infected Greek children.

Sgouras DN, Panayotopoulou EG, Papadakos K, Martinez-Gonzalez B, Roumbani A, Panayiotou J, vanVliet-Constantinidou C, Mentis AF, Roma-Giannikou E.

J Clin Microbiol. 2009 Aug;47(8):2426-34. doi: 10.1128/JCM.00159-09. Epub 2009 Jun 17.

22.

In vitro and in vivo safety evaluation of the bacteriocin producer Streptococcus macedonicus ACA-DC 198.

Maragkoudakis PA, Papadelli M, Georgalaki M, Panayotopoulou EG, Martinez-Gonzalez B, Mentis AF, Petraki K, Sgouras DN, Tsakalidou E.

Int J Food Microbiol. 2009 Jul 31;133(1-2):141-7. doi: 10.1016/j.ijfoodmicro.2009.05.012. Epub 2009 May 15.

PMID:
19515446
23.

The paraphyletic composition of Leishmania donovani zymodeme MON-37 revealed by multilocus microsatellite typing.

Alam MZ, Haralambous C, Kuhls K, Gouzelou E, Sgouras D, Soteriadou K, Schnur L, Pratlong F, Schönian G.

Microbes Infect. 2009 May-Jun;11(6-7):707-15. doi: 10.1016/j.micinf.2009.04.009. Epub 2009 Apr 17.

PMID:
19376262
24.

Cocirculation of genotypes D4 and D6 in Greece during the 2005 to 2006 measles epidemic.

Kokotas SN, Bolanaki E, Sgouras D, Pogka V, Logotheti M, Kossivakis A, Horefti E, Papadakos K, Mentis A.

Diagn Microbiol Infect Dis. 2008 Sep;62(1):58-66. doi: 10.1016/j.diagmicrobio.2008.06.001. Epub 2008 Jul 14.

PMID:
18621499
25.

Strategy to characterize the number and type of repeating EPIYA phosphorylation motifs in the carboxyl terminus of CagA protein in Helicobacter pylori clinical isolates.

Panayotopoulou EG, Sgouras DN, Papadakos K, Kalliaropoulos A, Papatheodoridis G, Mentis AF, Archimandritis AJ.

J Clin Microbiol. 2007 Feb;45(2):488-95. Epub 2006 Dec 6.

26.

In vitro and in vivo activities of Chios mastic gum extracts and constituents against Helicobacter pylori.

Paraschos S, Magiatis P, Mitakou S, Petraki K, Kalliaropoulos A, Maragkoudakis P, Mentis A, Sgouras D, Skaltsounis AL.

Antimicrob Agents Chemother. 2007 Feb;51(2):551-9. Epub 2006 Nov 20.

27.

Lactobacillus johnsonii La1 attenuates Helicobacter pylori-associated gastritis and reduces levels of proinflammatory chemokines in C57BL/6 mice.

Sgouras DN, Panayotopoulou EG, Martinez-Gonzalez B, Petraki K, Michopoulos S, Mentis A.

Clin Diagn Lab Immunol. 2005 Dec;12(12):1378-86.

28.

In vitro and in vivo inhibition of Helicobacter pylori by Lactobacillus casei strain Shirota.

Sgouras D, Maragkoudakis P, Petraki K, Martinez-Gonzalez B, Eriotou E, Michopoulos S, Kalantzopoulos G, Tsakalidou E, Mentis A.

Appl Environ Microbiol. 2004 Jan;70(1):518-26.

29.

Transcriptional repressor ERF is a Ras/mitogen-activated protein kinase target that regulates cellular proliferation.

Le Gallic L, Sgouras D, Beal G Jr, Mavrothalassitis G.

Mol Cell Biol. 1999 Jun;19(6):4121-33.

31.
32.

Poly(amidoamine)s with potential as drug carriers: degradation and cellular toxicity.

Ranucci E, Spagnoli G, Ferruti P, Sgouras D, Duncan R.

J Biomater Sci Polym Ed. 1991;2(4):303-15.

PMID:
1772834

Supplemental Content

Loading ...
Support Center